William R. Roeske

William R. Roeske's AcademicInfluence.com Rankings

William R. Roeske

Medical

#3133

World Rank

#3588

Historical Rank

Pharmacology

#372

World Rank

#423

Historical Rank

medical Degrees

Download Badge

Medical

William R. Roeske's Degrees

PhD Pharmacology University of California, San Francisco
Bachelors Pharmacy University of California, San Francisco

Why Is William R. Roeske Influential?

(Suggest an Edit or Addition)

(See a Problem?)

William R. Roeske's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Cardiac muscarinic cholinergic receptors. Biochemical identification and characterization. (1978) (304)
A unique regulatory profile and regional distribution of [3H]pirenzepine binding in the rat provide evidence for distinct M1 and M2 muscarinic receptor subtypes. (1983) (288)
SR141716A is an inverse agonist at the human cannabinoid CB1 receptor. (1997) (269)
Noninvasive Evaluation of Ventricular Hypertrophy in Professional Athletes (1976) (235)
The binding of [3H]nitrendipine to receptors for calcium channel antagonists in the heart, cerebral cortex, and ileum of rats. (1982) (219)
Systemic toxic effects associated with high-dose verapamil infusion and chemotherapy administration. (1991) (185)
Molecular biology and pharmacology of cloned opioid receptors 1 (1995) (179)
[3h]pirenzepine selectively identifies a high affinity population of muscarinic cholinergic receptors in the rat cerebral cortex. (1982) (171)
The interaction of [3H]nitrendipine with receptors for calcium antagonists in the cerebral cortex and heart of rats. (1982) (167)
The delta-opioid receptor: molecular pharmacology, signal transduction, and the determination of drug efficacy. (1999) (162)
Muscarinic antagonist binding site heterogeneity as evidenced by autoradiography after direct labeling with [3H]-QNB and [3H]-pirenzepine. (1984) (141)
The cloning and expression of a human creatine transporter. (1994) (131)
Characterization of alpha-1 adrenergic receptors in the heart using [3H]WB4101: effect of 6-hydroxydopamine treatment. (1980) (126)
Cardiac muscarinic cholinergic receptor binding is regulated by Na+ and guanyl nucleotides. (1980) (125)
[3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes. (1986) (119)
Identification of a human delta opioid receptor: cloning and expression. (1994) (112)
High affinity specific [3H](+)PN 200-110 binding to dihydropyridine receptors associated with calcium channels in rat cerebral cortex and heart. (1984) (106)
High affinity [3H]flunitrazepam binding: characterization, localization, and alteration in hypertension. (1981) (105)
Molecular pharmacology of muscarinic receptor heterogeneity. (1989) (104)
Hormonal regulation of myosin heavy chain and alpha-actin gene expression in cultured fetal rat heart myocytes. (1987) (104)
Response of atrial fibrillation to therapy: role of etiology and left atrial diameter. (1980) (102)
An allosteric model for benzodiazepine receptor function. (1983) (99)
Sodium-dependent high-affinity binding of [3H]hemicholinium-3 in the rat brain: a potentially selective marker for presynaptic cholinergic sites. (1984) (98)
Differential light microscopic autoradiographic localization of muscarinic cholinergic receptors in the brainstem and spinal cord of the rat using [3H]pirenzepine. (1983) (94)
Diltiazem enhancement of [3H]nitrendipine binding to calcium channel associated drug receptor sites in rat brain synaptosomes. (1982) (92)
Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain. (1997) (92)
Alterations in cardiac autonomic receptors following 6-hydroxydopamine treatment in rats. (1980) (91)
The benzodiazepine receptor: its development and its modulation by gamma-aminobutyric acid. (1980) (90)
Quantitative light microscopic autoradiography of [3H]hemicholinium-3 binding sites in the rat central nervous system: a novel biochemical marker for mapping the distribution of cholinergic nerve terminals (1985) (88)
Effects of bilateral ibotenate-induced lesions of the nucleus basalis magnocellularis upon selective cholinergic biochemical markers in the rat anterior cerebral cortex (1985) (86)
The regulation of muscarinic cholinergic receptors by guanine nucleotides in cardiac tissue. (1979) (85)
Muscarinic receptor: regulation by guanine nucleotides, ions, and N-ethylmaleimide. (1981) (80)
Ontogeny of mammalian myocardial β-adrenergic receptors (1979) (77)
Multiple benzodiazepine receptors and their regulation by γ-aminobutyric (1981) (71)
The influence of guanyl-5'-yl imidodiphosphate and sodium on muscarinic receptor binding in the rat brain and longitudinal muscle of the rat ileum. (1980) (71)
Muscarinic receptor binding in rat brain using the agonist, [3H]cis methyldioxolane. (1980) (69)
AM630 antagonism of cannabinoid-stimulated [35S]GTPγS binding in the mouse brain (1997) (65)
Fate of therapy failures in adult idiopathic thrombocytopenic purpura. (1980) (63)
Endomorphin-1 and endomorphin-2 are partial agonists at the human mu-opioid receptor. (1998) (63)
Alterations in central and peripheral adrenergic receptors in deoxycorticosterone/salt hypertensive rats. (1980) (60)
δ-Opioid receptor agonists produce antinociception and [35S]GTPγS binding in μ receptor knockout mice (2000) (59)
The Intact Human Neuroblastoma Cell (SH‐SY5Y) Exhibits High‐Affinity [3H]Pirenzepine Binding Associated with Hydrolysis of Phosphatidylinositols (1988) (58)
Unique agonist-bound cannabinoid CB1 receptor conformations indicate agonist specificity in signaling. (2008) (58)
Regulation of muscarinic receptor binding by guanine nucleotides and N-ethylmaleimide. (1980) (58)
delta 9-Tetrahydrocannabinol is a partial agonist of cannabinoid receptors in mouse brain. (1997) (58)
Effect of canine cardiac nerves on heart rate, rhythm, and pacemaker location. (1986) (55)
Involvement of Raf-1 in chronic delta-opioid receptor agonist-mediated adenylyl cyclase superactivation. (2002) (55)
AM630 is a competitive cannabinoid receptor antagonist in the guinea pig brain. (1997) (55)
AM630 is an inverse agonist at the human cannabinoid CB1 receptor. (1998) (54)
Neuroendocrine properties of intrinsic cardiac adrenergic cells in fetal rat heart. (2005) (52)
Pharmacological differences between the high-affinity muscarinic agonist binding states of the rat heart and cerebral cortex labeled with (+)-[3H]cismethyldioxolane. (1984) (52)
Converging Protein Kinase Pathways Mediate Adenylyl Cyclase Superactivation upon Chronic δ-Opioid Agonist Treatment (2003) (50)
Activation Sequence and Potential Distribution Maps Demonstrating Multicentric Atrial Impulse Origin in Dogs (1984) (50)
Modulation of benzodiazepine receptor binding: insight into pharmacological efficacy. (1982) (50)
Structure-activity relationships for SNC80 and related compounds at cloned human delta and mu opioid receptors. (1996) (49)
Independent expression of cardiac type I and II cyclic AMP-dependent protein kinase during murine embryogenesis and postnatal development. (1979) (49)
Agonist binding to multiple muscarinic receptors. (1984) (48)
A cholinergic antagonist identifies a subclass of muscarinic receptors in isolated rat pancreatic acini. (1987) (47)
Quantitative relation between sites of atrial impulse origin and cycle length. (1983) (46)
Temperature-dependent modulation of [3H]nitrendipine binding by the calcium channel antagonists verapamil and diltiazem in rat brain synaptosomes. (1984) (45)
gamma-Aminobutyric acid enhancement of CL 218,872 affinity and evidence of benzodiazepine receptor heterogeneity. (1981) (45)
The cloned murine M1 muscarinic receptor is associated with the hydrolysis of phosphatidylinositols in transfected murine B82 cells. (1988) (45)
Molecular mechanisms of excitatory signaling upon chronic opioid agonist treatment. (2003) (44)
Identification of adenylyl cyclase isoenzymes in CHO and B82 cells. (1998) (44)
The m2 muscarinic acetylcholine receptors are coupled to multiple signaling pathways via pertussis toxin-sensitive guanine nucleotide regulatory proteins. (1991) (43)
Human delta opioid receptor: functional studies on stably transfected Chinese hamster ovary cells after acute and chronic treatment with the selective nonpeptidic agonist SNC-80. (1996) (43)
Regional differences in ethylcholine mustard aziridinium ion (AF64A)-induced deficits in presynaptic cholinergic markers for the rat central nervous system. (1985) (43)
Agonist-specific regulation of the δ-opioid receptor (2004) (42)
The third extracellular loop of the human delta-opioid receptor determines the selectivity of delta-opioid agonists. (1996) (42)
Repeated morphine treatment-mediated hyperalgesia, allodynia and spinal glial activation are blocked by co-administration of a selective cannabinoid receptor type-2 agonist (2012) (41)
Effects of beta-adrenergic blockade on papillary muscle function and the beta-adrenergic receptor system in noninfarcted myocardium in compensated ischemic left ventricular dysfunction. (1992) (41)
[3H]AF-DX 116 labels subsets of muscarinic cholinergic receptors in rat brain and heart. (1987) (40)
Antisense oligodeoxynucleotide treatment to the brain cannabinoid receptor inhibits antinociception (1996) (40)
The benzodiazepine receptor of mammalian brain. (1980) (39)
In vivo identification of calcium antagonist binding sites using [3H]nitrendipine. (1983) (39)
Cloning of the rat M3, M4 and M5 muscarinic acetylcholine receptor genes by the polymerase chain reaction (PCR) and the pharmacological characterization of the expressed genes. (1992) (39)
Differential ontogeny of putative M1 and M2 muscarinic receptor binding sites in the murine cerebral cortex and heart. (1985) (38)
gamma-Aminobutyric acid regulation of the benzodiazepine receptor: biochemical evidence for pharmacologically different effects of benzodiazepines and propyl beta-carboline-3-carboxylate. (1981) (38)
Differential regulation of muscarinic agonist binding sites following chronic cholinesterase inhibition. (1980) (37)
Muscarinic cholinergic ligand binding to intact mouse pituitary tumor cells (AtT-20/D16-16) coupling with two biochemical effectors: adenylate cyclase and phosphatidylinositol turnover. (1986) (36)
The regulation of cardiac alpha 1-adrenergic receptors by guanine nucleotides and by muscarinic cholinergic agonists. (1980) (36)
Mediating delta-opioid-initiated heart protection via the beta2-adrenergic receptor: role of the intrinsic cardiac adrenergic cell. (2007) (36)
[3H]Pirenzepine identifies putative M1 muscarinic receptors in human stellate ganglia (1984) (36)
Expression of α-Transducin in Chinese Hamster Ovary Cells Stably Transfected with the Human δ-Opioid Receptor Attenuates Chronic Opioid Agonist-Induced Adenylyl Cyclase Superactivation (2001) (35)
Relative efficacies of δ-opioid receptor agonists at the cloned human δ-opioid receptor (1997) (34)
Sustained morphine treatment augments basal CGRP release from cultured primary sensory neurons in a Raf-1 dependent manner. (2008) (33)
In vitro osmoregulation of taurine in fetal mouse hearts. (1984) (33)
Striatal muscarinic receptors: regulation by dopaminergic agonists. (1981) (32)
Quantitative autoradiography of M2 muscarinic receptors in the rat brain identified by using a selective radioligand [3H]AF-DX 116 (1989) (32)
Reduced density of sodium-dependent [3H]hemicholinium-3 binding sites in the anterior cerebral cortex of rats following chemical destruction of the nucleus basalis magnocellularis. (1984) (32)
Phosphorylation of adenylyl cyclase VI upon chronic δ-opioid receptor stimulation (1999) (30)
Characterization of muscarinic acetylcholine receptors in human labial salivary glands. (1990) (29)
Adenylate cyclase and beta adrenergic receptor development in the mouse heart. (1982) (29)
Tachykinin NK₁ receptor antagonist co-administration attenuates opioid withdrawal-mediated spinal microglia and astrocyte activation. (2012) (29)
The relationship between agonist states of the M1 muscarinic receptor and the hydrolysis of inositol lipids in transfected murine fibroblast cells (B82) expressing different receptor densities. (1989) (29)
Human δ opioid receptor: A stable cell line for functional studies of opioids (1995) (28)
Accuracy of M mode echocardiographic measurements of the left ventricle. (1982) (28)
Agonist-specific down-regulation of the human δ-opioid receptor (2003) (27)
The differential loss of [3H]pirenzepine vs [3H] (-) quinuclidinylbenzilate binding to soluble rat brain muscarinic receptors indicates that pirenzepine binds to an allosteric state of the muscarinic receptor. (1984) (27)
Properties of TAN-67, a nonpeptide δ-opioid receptor agonist, at cloned human δ-and μ-opioid receptors (1995) (27)
Differential regulation of high-affinity agonist binding to muscarinic sites in the rat heart, cerebellum, and cerebral cortex. (1983) (27)
Characterization of a carrier-mediated transport system for taurine in the fetal mouse heart in vitro. (1978) (27)
Muscarinic receptors and novel strategies for the treatment of age-related brain disorders. (1994) (26)
3H-flunitrazepam binding to bovine retina and the effect of GABA thereon (1980) (26)
Functional and biochemical basis for multiple muscarinic acetylcholine receptors (1985) (25)
Muscarinic cholinergic receptor heterogeneity (1982) (25)
Chimeric M1/M2 muscarinic receptors: correlation of ligand selectivity and functional coupling with structural modifications. (1992) (24)
Pharmacological characterization of the M1 muscarinic receptors expressed in murine fibroblast B82 cells. (1989) (24)
The cloning and sequence analysis of the rat serotonin-1A receptor gene. (1990) (23)
AM630 antagonism of cannabinoid-stimulated [35S]GTP gamma S binding in the mouse brain. (1997) (23)
The coupling of muscarinic receptors to hydrolysis of inositol lipids in human neuroblastoma SH-SY5Y cells (1989) (23)
Responsiveness to drugs and hormones in the murine model of cardiac ontogenesis. (1981) (23)
Differential down-regulation of the human δ-opioid receptor by SNC80 and [d-Pen2,d-Pen5]enkephalin (2000) (23)
Maturation of mammalian myocardial muscarinic cholinergic receptors. (1978) (23)
Left ventricular performance in conscious thyrotoxic calves. (1982) (23)
The Nature of Muscarinic Receptor Binding (1983) (22)
Sustained Morphine Treatment Augments Capsaicin-Evoked Calcitonin Gene-Related Peptide Release from Primary Sensory Neurons in a Protein Kinase A- and Raf-1-Dependent Manner (2009) (22)
New paradigms and tools in drug design for pain and addiction (2006) (22)
Muscarinic receptor-mediated hydrolysis of phosphatidylinositols in human neuroblastoma (SH-SY5Y) cells is sensitive to pertussis toxin (1988) (21)
delta-Opioid receptor: the third extracellular loop determines naltrindole selectivity. (1996) (21)
Effects of chemical sympathectomy with 6-hydroxydopamine on α- and β-adrenoceptors and muscarinic cholinoceptors in rat kidney (1986) (21)
Clinicopathologic Correlations in Patients after Myocardial Infarction (1981) (21)
β2‐ADRENOCEPTORS REGULATE INDUCTION OF MYOCARDIAL ORNITHINE DECARBOXYLASE IN MICE in vivo (1982) (21)
[3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes. (1986) (21)
Chronic morphine-mediated adenylyl cyclase superactivation is attenuated by the Raf-1 inhibitor, GW5074. (2006) (20)
Renal benzodiazepine binding increases during deoxycorticosterone/salt hypertension in rats. (1980) (20)
New endomorphin analogs with mu-agonist and delta-antagonist properties (2004) (20)
Agonist-specific regulation of the delta-opioid receptor. (2004) (20)
Factors influencing enzyme release from cultured fetal mouse hearts deprived of oxygen and glucose. (1978) (20)
Pharmacologic comparison of selected agonists for the M1 muscarinic receptor in transfected murine fibroblast cells (B82). (1991) (20)
Mathematical analysis of the kinetics of competitive inhibition in neurotransmitter receptor binding assays. (1981) (20)
Autoradiographic localization of muscarinic agonist binding sites in the rat central nervous system with (+)-cis-[3H]methyldioxolane (1985) (19)
The influence of guanyl-5'-yl imidodiphosphate and sodium chloride on the binding of the muscarinic agonist, [3H] cis methyldioxolane. (1980) (19)
Sustained morphine treatment augments prostaglandin E2-evoked calcitonin gene-related peptide release from primary sensory neurons in a PKA-dependent manner. (2010) (19)
Characterization of postsynaptic beta-adrenergic receptors and presynaptic muscarinic cholinergic receptors in the rat spleen. (1982) (19)
Himbacine recognizes a high affinity subtype of M2 muscarinic cholinergic receptors in the rat cerebral cortex (1988) (19)
Quantitative Evaluation of Human δ Opioid Receptor Desensitization Using the Operational Model of Drug Action (2007) (19)
Pharmacological comparison of the cloned human and rat M2 muscarinic receptor genes expressed in the murine fibroblast (B82) cell line. (1998) (19)
The role of the G protein γ2 subunit in opioid antinociception in mice (2000) (19)
Pharmacological characterization of a novel muscarinic partial agonist, YM796, in transfected cells expressing the m1 or m2 muscarinic receptor gene. (1992) (19)
Ontogeny of mammalian myocardial beta-adrenergic receptors. (1979) (18)
Benzodiazepine receptor heterogeneity: possible molecular basis and functional significance. (1984) (18)
High-affinity [3H]pirenzepine binding to putative M1 muscarinic sites in the neuroblastoma x glioma hybrid cell line (NG 108-15). (1984) (18)
Autoradiographic localization of nicotinic receptor binding in rat brain using [3H]methylcarbamylcholine, a novel radioligand. (1987) (18)
The efficacy of δ-opioid receptor-selective drugs (1998) (17)
Mutation W284L of the human delta opioid receptor reveals agonist specific receptor conformations for G protein activation. (2001) (16)
Intrathecal Raf-1-selective siRNA attenuates sustained morphine-mediated thermal hyperalgesia. (2008) (15)
Amplification of the rat M2 muscarinic receptor gene by the polymerase chain reaction: functional expression of the M2 muscarinic receptor. (1990) (15)
The regulation of cardiac muscarinic cholinergic receptors by isoproterenol. (1980) (15)
delta-Opioid receptor agonists produce antinociception and [35S]GTPgammaS binding in mu receptor knockout mice. (2000) (15)
Potent enhancement of [3H]nitrendipine binding in rat cerebral cortical and cardiac homogenates: a putative mechanism for the action of MDL 12,330A. (1985) (15)
Partial functional reconstitution of the cardiac muscarinic cholinergic receptor. (1984) (15)
Characterization of a cloned rat serotonin 5-HT1A receptor expressed in the HeLa cell line. (1993) (15)
Identification and Characterization of Muscarinic Receptors in Cultured Human Pancreatic Carcinoma Cells (1989) (15)
The fetal mouse heart in organ culture: maintenance of the differentiated state. (1980) (14)
Agonist-specific down-regulation of the human delta-opioid receptor. (2003) (14)
Differential regulation of M2 muscarinic receptors by guanine nucleotides in rat cerebral cortical and cardiac membranes. (1987) (14)
Solubilization with digitonin alters the kinetics of pirenzepine binding to muscarinic receptors from rat forebrain and heart. (1987) (13)
The ontogeny of specific binding sites for the calcium channel antagonist, nitrendipine, in mouse heart and brain (1983) (13)
Decreased [3H]nitrendipine binding in the brainstem of deoxycorticosterone-NaCl hypertensive rats. (1985) (13)
Stereochemistry of sterol biosynthesis: interrelationship of the terminal methyl groups in squalene, the C-1,1′ methyls in squalene 2,3-oxide, and the C-30,31 methyls in lanosterol (1969) (13)
Morphine promotes phosphorylation of the human δ-opioid receptor at serine 363 (2005) (13)
Relative efficacies of delta-opioid receptor agonists at the cloned human delta-opioid receptor. (1997) (12)
Reductions in retinal gamma-aminobutyric acid (GABA) content and in [3H]flunitrazepam binding after postnatal monosodium glutamate injections in rats. (1981) (12)
Down-regulation and desensitization of the muscarinic M1 and M2 receptors in transfected fibroblast B82 cells. (1994) (12)
(2S, 3R)TMT-L-Tic-OH is a potent inverse agonist at the human δ-opioid receptor (1999) (12)
A simple and rapid radio-receptor assay for the estimation of acetylcholine. (1982) (12)
Expression of alpha-transducin in Chinese hamster ovary cells stably transfected with the human delta-opioid receptor attenuates chronic opioid agonist-induced adenylyl cyclase superactivation. (2001) (12)
The measurement of free nitrendipine in human serum by an equilibrium dialysis - radioreceptor assay. (1983) (12)
Antinociception depends on the presence of G protein γ2-subunits in brain (2005) (12)
Predictive factors and mechanism of arrhythmias and myocardial ischaemic changes in elderly patients during barium enema. (1976) (12)
Postural position and neurocardiogenic syncope in late pregnancy. (2003) (11)
Isoproterenol stimulation of ornithine decarboxylase blocked by propranolol during ontogeny of the murine heart. (1981) (11)
Lactamimides: a novel chemical class of calcium antagonists with diltiazem-like properties. (1989) (11)
Trp284 of the Human δ Opioid Receptor is Required for SNC121 Binding but Not Binding of pCl-DPDPE, Deltorphin II or Naltrindole (1995) (11)
Accelerated communication a cloned NK2 receptor mediates phosphatidylinositol hydrolysis in a transfected murine fibrolast (1990) (11)
Differential regulation of putative M1/M2 muscarinic receptors: implications for different receptor-effector coupling mechanisms. (1984) (10)
Morphine promotes phosphorylation of the human delta-opioid receptor at serine 363. (2005) (10)
Phosphorylation of adenylyl cyclase VI upon chronic delta-opioid receptor stimulation. (1999) (10)
Decreased muscarinic receptor density in the aged rat brain. (1988) (10)
Heterogeneity of Benzodiazepine Receptors (1984) (10)
Light microscopic autoradiographic localization of [3H]pirenzepine and [3H](-)quinuclidinyl benzilate binding in human stellate ganglia. (1984) (10)
Properties of TAN-67, a nonpeptidic delta-opioid receptor agonist, at cloned human delta- and mu-opioid receptors. (1995) (10)
(2S,3R)β-Methyl-2′,6′-dimethyltyrosine-l-tetrahydroisoquinoline-3-carboxylic acid [(2S,3R)TMT-l-Tic-OH] Is a Potent, Selective δ-Opioid Receptor Antagonist in Mouse Brain (2003) (10)
Thermally induced myocardial preservation and necrosis in deprived fetal mouse hearts. (1977) (9)
New endomorphin analogs with -agonist and -antagonist properties* (2004) (8)
Incidence of arrhythmias and ST-segment changes in elderly patients during barium enema studies. (1975) (8)
[3H]pirenzepine specifically labels a high affinity muscarinic receptor in the rat cerebral cortex. (1983) (8)
Clinical pathologic correlates in acute myocardial infarction. (1978) (8)
Multiple benzodiazepine receptors and their regulation by gamma-aminobutyric acid. (1981) (7)
A cloned NK2 receptor mediates phosphatidylinositol hydrolysis in a transfected murine fibroblast (1990) (7)
(2S,3R)TMT-L-Tic-OH is a potent inverse agonist at the human delta-opioid receptor. (1999) (7)
Examination of Cholinergic and Neuropeptide Receptor Alterations in Senile Dementia of the Alzheimer’s Type (SDAT) (1986) (7)
Dopaminergic regulation of muscarinic receptor binding in the corpus striatum. (1981) (7)
DEVELOPMENT OF AUTONOMIC RECEPTORS IN THE FETAL MOUSE HEART (1979) (7)
Thermodynamic analyses of pirenzepine binding to membrane-bound and solubilized muscarinic receptors from rat forebrain and heart. (1987) (7)
Coupling of Human δ-Opioid Receptor to Retinal Rod Transducin in Chinese Hamster Ovary Cells (2000) (7)
Myocardial infarction. How representative are autopsied subjects with this clinical entity? (1981) (7)
Demonstration of a neurokinin A receptor subtype in transfected fibroblasts. (1992) (7)
Recent advances in muscarinic receptor heterogeneity and regulation. (1983) (7)
Human delta opioid receptor: a stable cell line for functional studies of opioids. (1995) (6)
Carrier-mediated taurine uptake in the fetal mouse heart. (1977) (6)
Behavior of sterols of insect muscle during homogenization and differential centrifugation. (1968) (6)
Differential down-regulation of the human delta-opioid receptor by SNC80 and [D-Pen(2),D-Pen(5)]enkephalin. (2000) (6)
Neurokinin A receptors are coupled to calcium mobilization in transfected fibroblasts. (1991) (6)
Mutation S363A in the human delta-opioid receptor selectively reduces down-regulation by a peptide agonist. (2004) (5)
Alterations in muscarinic cholinergic receptors in transplanted rat hearts (1978) (5)
Taurine transport in the fetal mouse heart. (1977) (4)
Irreversible inhibition by tyrosine-directed alkylating reagents of muscarinic cholinergic receptors in membranes from rat forebrain and heart. (1988) (4)
Erratum: The third extracellular loop of the human δ opioid receptor determines the selectivity of δ opioid agonist (Molecular Pharmacology (1996) 50 (1619-1624)) (1997) (4)
Mediating -Opioid-Initiated Heart Protection via the 2-Adrenergic Receptor: Role of the Intrinsic Cardiac Adrenergic Cell Short Title: Mediating Cardioprotection by the Intrinsic Cardiac Adrenergic Cell (2007) (4)
AUTORADIOGRAPHIC LOCALIZATION OF SUBTYPES OF MUSCARINIC AGONIST AND ANTAGONIST BINDING SITES: ALTERATIONS FOLLOWING CNS LESIONS (1986) (4)
Muscarinic receptor binding in the mouse heart: the selective modulatory effect of fluoride ion on agonist binding. (1982) (4)
Ontogeny of mammalian cardiac alpha 1-adrenergic receptors. (1980) (4)
β-Adrenergic receptor and adenyl cyclase development in the mouse heart (1980) (3)
The role of the G protein gamma(2) subunit in opioid antinociception in mice. (2000) (3)
The molecular properties of the M1 muscarinic receptor and its regulation of cytosolic calcium in a eukaryotic gene expression system. (1991) (3)
Antinociception depends on the presence of G protein gamma2-subunits in brain. (2005) (3)
Effects of chemical sympathectomy with 6-hydroxydopamine on alpha- and beta-adrenoceptors and muscarinic cholinoceptors in rat kidney. (1986) (3)
Structural correlates for down-regulation of m1 and m2 muscarinic receptor subtypes (1998) (3)
An increase in cardiac alpha1-adrenoceptors following chronic clonidine treatment (1982) (3)
Regulation of Muscarinic Receptor Binding (1981) (3)
Sustained cannabinoid agonist treatment augments CGRP release in a PKA-dependent manner (2009) (3)
The efficacy of delta-opioid receptor-selective drugs. (1998) (3)
Specific high-affinity [3H]Ro5-4864 Ro5-4864 benzodiazepine binding sites in the brain and periphery. (1985) (3)
The effect of GABA on the binding of 3H-flunitrazepam in mouse brains during development (1979) (2)
The benzodiazepine receptor: complex binding properties and the influence of GABA. (1983) (2)
Coupling of human delta-opioid receptor to retinal rod transducin in Chinese hamster ovary cells. (2000) (2)
Biochemical demonstration of muscarinic cholinergic receptors in mammalian heart (1977) (2)
Presynaptic muscarinic cholinergic and postsynaptic beta-adrenergic receptors in splenic tissue. (1983) (2)
Agonist radioligands for identifying functional neurotransmitter receptors. Introduction. (1984) (2)
Allosteric modulation by diltiazem and verapamil of [3H]nitrendipine binding to calcium channel sites in rat brain. (1983) (2)
Myocardial muscarinic cholinergic receptors (1977) (1)
Incidence of significant arrhythmias in elderly patients during barium enema (1974) (1)
Isoproterenol induction of ornithine decarboxylase during ontogeny of the murine heart (1979) (1)
A radioreceptor assay for estimation of acetylcholine. (1982) (1)
Identification of calcium-channel receptors in intact animals. (1985) (1)
Desensitization of neurokinin A receptors expressed by B82 fibroblasts. (1993) (1)
(2S,3R) beta-methyl-2',6'-dimethyltyrosine-L-tetrahydroisoquinoline-3-carboxylic acid [(2S,3R)TMT-L-Tic-OH] is a potent, selective delta-opioid receptor antagonist in mouse brain. (2003) (1)
Mechanisms of cardiac arrhythmias: Muscarinic cholinergic receptor alterations in the production of asystole (1979) (1)
Characterization of muscarinic receptors on intact human neuroblastoma cells: coupling to phosphoinositide hydrolysis and phosphorylation by phorbol esters (1986) (0)
Inverse agonism at the delta opioid receptors (2003) (0)
Bnezodiazepine Benzodiazepine binding using [3H]propyl β-carboline-3-carboxylate (1981) (0)
Coupling of Human d -Opioid Receptor to Retinal Rod Transducin in Chinese Hamster Ovary Cells 1 (1999) (0)
Book ReviewThe Modern Management of Congestive Heart Failure (1983) (0)
Regulation of (-)epinephrine high affinity state of (β-adrenoceptors in the rat heart left ventricles (1983) (0)
Alterations in central and peripheral receptors (R) in salt deoxycorticosterone (DOCA) treated rats (1980) (0)
Effects of /3-Adrenergic Blockade on Papillary Muscle Function and the /3-Adrenergic Receptor System in Noninfarcted (2005) (0)
[3H]Pirenzepine and [3H](-)quinuclidinylbenzilate binding to putative M1 And M2 muscarinic sites in deoxycorticosterone-NACL hypertensive rats (1985) (0)
Cardiac calcium antagonist channels labelled by [3H]nitrendepine: Characterization, drug and ionic specificity (1982) (0)
Pharmacological comparison of the cloned rat and human M2 muscarinic receptor genes expressed in the murine fibroblast (B82) cell line (1993) (0)
Pharmacologic comparison of the cloned M1 and M2 muscarinic receptors of the rat expressed in murine fibroblast cells (1990) (0)
The selective regulatory effect of fluoride ion on muscarinic agonist binding in mouse myocardium (1982) (0)
Characterization of cardiac α1-adrenergic receptors by [3H]WB4101 and alteration following chemical sympathectomy (1981) (0)
Complex binding properties of the benzodiazepine receptor (1982) (0)
Antagonist affinity states of cardiac α-adrenoceptors and their regulation (1982) (0)
Identification of Putative M1 Muscarinic Receptors Using [3H]Pirenzepine: Characterization of Binding and Autoradiographic Localization in Human Stellate Ganglia (1986) (0)
Post-synaptic β-adrenergic receptors increase and pre-synaptic muscarinic receptors decrease in splenic tissue after 6-hydroxydopamine treatment (1981) (0)
Alterations in cholinergic muscarinic receptors in transplanted rat hearts (1978) (0)
Taurine uptake system in the embryo mouse heart (1977) (0)
Postnatal development and regulation of the muscarinic receptor in the mouse heart using the agonist [3H]CIS methyldioxolane (1981) (0)
Cloning, expression and pharmacological characterization of a human delta opioid receptor: 26.6 (1995) (0)
Methoxyphenethylamine-ergoline hybrids Novel muscarinic ligands (1995) (0)
Cardiac muscarinic receptors: Regulation of the agonist binding using the ligand [3H]-cismethyldioxolane (CD) (1980) (0)
Mediating (cid:1) -opioid-initiated heart protection via the (cid:2) 2 -adrenergic receptor: role of the intrinsic cardiac adrenergic cell (2007) (0)
Short communication Mutation S363A in the human y-opioid receptor selectively reduces down-regulation by a peptide agonist (2004) (0)
Accuracy of M-mode echo measurements of the left ventricle (1981) (0)
Structure-function correlation of muscarinic acetylfholine receptors (1992) (0)
Muscarinic cholinergic receptor-mediated regulation of isoproterenol stimulated cyclic AMP formation in rat cardiomyocytes (1985) (0)
Pathologic correlation between infarct size and severity of coronary athero sclerosis in man (1977) (0)
Correlation between pharmacological activity and the influence of GABA on the binding of flunitrazepam and the specific benzodiazepine antagonist, Ro 15-1788 (1982) (0)
High affinity specific [3H](+)PN 200-110 binding to a dihydropyridine receptor calcium channel complex in rat heart and cerebral cortex (1984) (0)
Guanine nucleotide and sodium ion regulation of agonist muscarinic cholinergic receptor binding (1980) (0)
Muscarinic cholinergic receptors in human myocardium (1979) (0)
Cloning and Expression of the Human Delta Opioid Receptor (2003) (0)
SNC80 specific down-regulation of the human δ-opioid receptor (hDOR) truncated at Gly338 (2000) (0)
Reductions in benzodiazepine binding following postnatal monosodium glutamate injections in rats (1981) (0)
Solubilized musarinic recognition sites from rat brain and heart: evidence in favor of a homogeneous population of sites (1986) (0)
Book ReviewCardiac Drug Therapy (1984) (0)
The GABA shift: A predictor of anxiolytic efficacy (1982) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With William R. Roeske?

William R. Roeske is affiliated with the following schools:

University of Szeged